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Abstract: Acute aortic dissection is a life-threatening condition associated with high morbidity 
and mortality. In this article, the authors review basic biology of the aorta and aortic dissection, 
epidemiology, clinical presentation, diagnostic approach, emergency stabilization measures, 
and the latest surgical approach for type B dissection.
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The tragedies of life are largely arterial.
–Sir William Osler1
Perspective
Diseases of the aorta are among the most feared conditions encountered in the 
emergency department. The term ‘acute aortic syndrome’ refers to a group of 
catastrophic diseases that affect the aorta. These include aneurysmal aortic rupture, 
intramural aortic hematoma, penetrating atherosclerotic ulcer, traumatic aortic 
transection, and acute aortic dissection (AAD).
Acute aortic dissection is not an infrequent clinical entity. With more than 20 cases 
per million per year, AAD is actually the most common catastrophe of the aorta. It is 
a time-sensitive and rapidly fatal disease: If left untreated, early mortality from type 
A AAD can be as high as 1% per hour, 50% at 72 hours, 75% at two weeks, and 90% 
at three months.2–5 While hourly mortality data for type B AAD are not available, the 
overall in-hospital mortality is reported to be 11%. For those patients in the highest 
risk group, type B mortality can be as high as 71%.6
The classic clinical presentation of type B AAD is that of a male patient in his 
60–70’s with a history of hypertension, who presents to the emergency department 
(ED) with the complaint of abrupt onset of severe, sharp, ripping chest and/or back 
pain. Patient appears in distress with pain, sweating, and anxious as in shock. Blood 
pressure may be normal or elevated. Physical examination may reveal a pulse deﬁ  cit, 
diastolic murmur, or focal neurological ﬁ  ndings. Deﬁ  nitive imaging methods usually 
include a computed tomography (CTA) angiography. Critically ill patients will need 
deﬁ  nitive airway support, ﬂ  uid resuscitation, blood pressure and heart rate control, 
and emergent open surgical or endovascular repair.
While type A AAD usually requires emergency surgical intervention, the major-
ity of type B AAD (282 out of 386 [73%] in a recent series by Suzuki) are managed 
medically.7 With advances in understanding of the pathogenesis and pathophysiology 
of AAD, improved and aggressive antiimpulsive management, and the improvements 
in surgical/endovascular techniques, mortality from AAD has improved signiﬁ  cantly. 
The aim of this manuscript is, ﬁ  rst, to give an overview of aortic dissection and second, 
to focus on the contemporary approach to the diagnosis and medical management of 
type B acute aortic dissection.Vascular Health and Risk Management 2009:5 54
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Etiology and pathogenesis
The heart serves as a positive displacement pump to supply 
blood to organs in humans. For every cardiac cycle, the left 
ventricle pushes (displaces) a ﬁ  xed amount of blood into 
the aorta, which serves not only as a conduit but also as a 
modulator and damper to convert this pulsatile blood ﬂ  ow 
into a even reservoir of blood supply to the issues. The aortic 
wall is made up of three layers: the inner layer of intima, 
the middle layer of media, and the outer layer of adventitia 
(Figure 1). The intima is made up of an endothelial lining, a 
highly active metabolically monolayer, which is supported by 
a sublayer of loose connective tissue. This intimal sublayer 
allows the intima to move relative to the media when the aorta 
expands or contracts during systole and diastole.
The media is made up of a meshwork of concentric 
fenestrated lamellar layers of elastin fibers (about 50). 
Interposed between the elastin ﬁ  ber layers are concentric 
smooth muscle cells and collagen ﬁ  bers, proteoglycans, and 
glycoproteins. Elastin ﬁ  bers are made of elastin, a highly 
stretchable material that is able to stretch up to 2–3x of its 
original length without rupture. Elastin is the material that 
gives the aorta its distensibility. Collagen ﬁ  bers, on the other 
hand, are very stiff and are up to 5,000 times stiffer than 
elastin. Collagen gives the aorta the structural integrity and 
resistance to hemodynamic stress as well as the shearing 
effects created by the force of blood ﬂ  ow. In addition, the 
rings of smooth muscle cells in the media also contribute to 
aorta vascular stiffness. Under the inﬂ  uence of autonomic 
control, smooth muscle cells in the media contract and relax, 
giving the aorta its vascular tone.
The outermost layer, the adventitia, is made of the 
tough collagen ﬁ  bers and connective tissue. Vasa vasorum 
(“vessels of the vessel”) are small blood vessels located in 
the adventitia and the outer part the media. These blood ves-
sels provide nutrients to the media and adventitia since the 
wall of the aorta is too thick to deride nourishment from the 
blood in the aortic lumen via diffusion.
Although it may appear overly simplistic, acute aortic 
dissection occurs when the aortic wall, already weakened by 
disease processes, is further subjected to elevated stress from 
systemic hypertension. Classic AAD begins with a tear in the 
intimal layer. Blood under pulsatile pressure subsequently 
forces the tear to open and dissects along the media layers in 
the diseased aortic wall, forming a false lumen(s) (Figure 2). 
The dissection can propagate distally, proximally, or both 
along the extent of the aorta. In the majority of cases (90%), 
as the dissection propagates, it also causes 1 secondary tear 
in the intimomedial layer, allowing blood to ﬂ  ow back to the 
true lumen of the aorta. While the primary entry site is usually 
in the thoracic aorta, the secondary site can be in the lower 
descending or abdominal aorta. AAD can be catastrophic 
because the dissecting false lumen can rupture, causing 
rapid exsanguination and death. The false lumen can also 
obstruct the arterial branches coming off the aorta, causing 
serious and potentially lethal complications. In type A AAD, 
these include stroke, acute myocardial infarction, pericardial 
tamponade, or aortic valve insufﬁ  ciency. In type B AAD, 
potential complications include intestinal ischemia, renal 
failure, paraplegia, and other malperfusion syndromes.
There are two similar pathological entities worth 
mentioning: intramural hematomas (IMH) and penetrating 
atherosclerotic ulcers (PAU). Patients with IMH or PAU have 
clinical presentations that are indistinguishable from AAD. 
IMH refers to a condition where there is a bleed within the 
aortic wall without the evidence of an intimomedial ﬂ  ap. It 
is often considered a precursor of the classic aortic dissec-
tion and thought to be the result of mechanical tearing of the 
vaso vasorum. The hematoma can expand inward causing a 
tear on the intimal side, causing blood to dissect along the 
extent of the aorta, resembling classic acute aortic dissection. 
PAU refers to a condition where there is an ulceration of 
atherosclerotic aortic plaques, usually in the descending 
thoracic and abdominal aorta. These lesions can lead to 
a penetration into the intimal borders and into the media, 
resembling a localized hematoma and an IMH. They can 
also start dissecting along the extent of the aorta, resembling 
a classic aortic dissection. The entry tear at the ulceration 
may be thicker and less mobile compared to the intimomedial 
ﬂ  ap seen in the classic aortic dissection. PAU tends to affect 
the descending thoracic aorta and the abdominal aorta. Its 
management is similar to type B AAD.
Risk factors
Both acquired conditions and connective tissue disorders 
are known to cause certain individuals to be at risk for 
acute aortic dissection. Data from the International Registry 
of Aortic Dissection (IRAD)6,8 showed the following risk 
factors in AAD: male sex, age, a history of hypertension 
or atherosclerosis, prior cardiac surgery including aortic 
valve surgery, a history of bicuspid aortic valve, or a his-
tory of Marfan syndrome. The average age for AAD was 
63.1 years, with type B slightly older (66.3 vs 61.2 years). 
65.3% of patients were male. 62.3% of the patients had 
type A dissection, 72.1% had a history of hypertension, 
and 4.9% had Marfan syndrome.6 Of particular interest to 
the physicians evaluating these patients in the emergency Vascular Health and Risk Management 2009:5 55
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department (ED), 7% of patients presenting with AAD 
were younger than 40 years of age. Compared to the typical 
AAD patients, these younger patients were more likely to 
have Marfan syndrome, bicuspid aortic valve, Ehlers-Danlos 
syndrome, Loeys-Dietz syndrome and a history prior cardiac 
surgery. In the evaluation of acute chest pain syndrome in 
the younger patients, suspicious chest pain with the above 
characteristics should raise the index of suspicion for acute 
aortic dissection. Table 1 summarizes the distinguishing 
features in these two patient populations.8
Vascular staging and classiﬁ  cation
Aortic dissection is categorized as acute or chronic depending 
on the onset of symptoms or dissection. If the symptoms or dis-
section occur within last 14 days, the dissection is termed acute 
aortic dissection (AAD). If the symptoms or dissection occur 
outside of the 14 days, the dissection is termed chronic aortic 
dissection. AAD is further classiﬁ  ed depending on the location 
of the dissection. In the DeBakey classiﬁ  cation (Figure 3A), 
type I refers to dissections that propagate from the ascending 
aorta, extend to the aortic arch, and commonly, beyond the arch 
distally. Type II refers to dissections that are conﬁ  ned to the 
ascending portion of the aorta. Type III dissections are limited 
to the descending aorta. Class III also includes the dissections 
that start in the descending aorta that extend proximally to the 
arch and ascending aorta. In the more commonly used Stanford 
classiﬁ  cation system (Figure 3B), type A refers to dissections 
that involve the ascending and transverse aorta regardless of 
the site of origin. Type B refers to dissections that involve 
only the descending aorta. Rarely, dissections that start in the 
descending aorta can also extend proximally into the aortic 
arch and the ascending aorta. This is a special case of type B 
dissection, and should be called retro-A dissection.
The term “complicated” type B AAD is used for 
patients who present with, or during the hospital course, 
develop the following: rupture, malperfusion syndromes, 
Intima
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Figure 1 Layers of aortic wall.Vascular Health and Risk Management 2009:5 56
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refractory pain, or rapid aortic expansion. This is an 
important distinction as patients with complicated type 
B AAD usually require immediate endovascular or open 
surgical intervention.
Clinical presentation
Insights into the clinical presentation of patients are gained 
from the International Registry of Acute Aortic dissection 
(IRAD).6 A prototypical patient with acute aortic dissection 
will be a man in his ﬁ  fth to seventh decade of life, whose 
past medical history is signiﬁ  cant for hypertension; patients 
younger than 40 years may report a history of Marfan 
syndrome, bicuspid aortic valve, Ehlers-Danlos syndrome, 
Loeys-Dietz syndrome or aortic valve surgery. The most 
common chief complaint is sudden onset of severe chest pain 
or back pain. Patients with type A more commonly report a 
history of anterior chest pain whereas type B more commonly 
report a history of back or abdominal pain. The pain may be 
described as sharp, and, less commonly, ripping or tearing, 
with radiation to back, neck, or abdomen. One out of six 
A B
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Figure 2 Aortic dissection.  Actual specimen (A) and intravascular imaging (B) show both the true and false lumen.
Table 1 Characteristics of patients (N = 951) with acute aortic dissection – from the International Registry of Acute Aortic 
Dissection8
Risk factor % of Patients 
Age  40 years (N = 68)
% of Patients 
Age  40 years (N = 883)
Age, years 30.7 63.9
Type A dissection 68 65
Type B dissection 32 35
Male 76 67
Medical and social history
Hypertension* 34 72
Atherosclerosis* 13 0
Known aortic aneurysm 19 13
Bicuspid aortic valve* (N = 516) 91
Known aortic valve disease 10 8
Marfan syndrome* 50 2
Peripartum 3 0
Cocaine-related 0 0.6
Diabetes mellitus 0 4
Previous history of cardiac surgery
Aortic valve replacement* 12 5
CABG 0 6
Prior history of aortic dissection 7 6
Note: *Statistically different between the two groups.Vascular Health and Risk Management 2009:5 57
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Figure 3A Debakey classiﬁ  cation.
Type I Type II Type III
syndrome that results from obstruction of celiac trunk, 
superior mesenteric, inferior mesenteric, renal arteries caus-
ing (frequently fatal) acute bowel ischemia and decreased 
renal blood ﬂ  ow and glomerular ﬁ  ltration.
The physical examination overall is deemed not 
sufﬁ  ciently sensitive to rule out an acute aortic dissection.9 
However, the examination can be useful in raising the 
likelihood of an aortic dissection and whether a patient 
with a probable aortic dissection may need emergent 
surgical intervention. When performing the physi-
cal examination, the ED physician should focus on the 
assessment of hemodynamic stability, prognostic signs 
of poor outcome, and signs of impending cardiovascular 
collapse. The ﬁ  ndings of pulse deﬁ  cits, blood pressure dif-
ferential of at least 20 mm Hg, or motor and sensory deﬁ  cits 
on neurological examination signiﬁ  cantly raise the likelihood 
ratio (LR 5.7) of an aortic dissection.9 A diastolic murmur 
of aortic regurgitation indicates possible involvement of the 
root of the ascending aorta. In a patient with hypotension, the 
presence of jugular venous distension or pulsus paradoxus 
indicates pericardial involvement and/or tamponade. These 
ﬁ  ndings should prompt the clinician to seek emergent diag-
nostic conﬁ  rmations and, at the same time, arrange for prompt 
cardiothoracic evaluation and intervention.
patients may ascribe a migratory quality to the pain (“I feel 
like the pain was going from my chest down to my legs”). The 
pain may wax and wane, sometimes with complete resolution 
of symptoms. In up to 4.5% of patients with aortic dissection, 
there was no pain reported. The absence of pain thus does not 
rule out an aortic dissection although it lowers the likelihood 
of a dissection (likelihood ratio, LR 0.3).9
In addition to the chest/back/abdominal pain, patients 
may present with generalized symptoms of dyspnea, 
diaphoresis, bloody diarrhea, nausea, and vomiting. These 
nonspeciﬁ  c symptoms, however, may be the prodrome of the 
ominous malperfusion syndrome. The clinical manifestation 
of the malperfusion syndrome depends on the anatomy of the 
affected vessels. Patients may present with signs or symptoms 
of a stroke, dizziness/syncope/aphasia/hemiplegia, if they 
have dynamic obstruction and malperfusion of coronary/
carotid/vertebral arteries. Alternatively, patients may 
complain of painful, plegic, pulseless, and cool extremities 
if the brachiocephalic, left subclavian arteries, distal aorta, 
iliac arteries are compromised. A dramatic paraplegia or 
quadriplegia is observed when the intercostal/segmental 
arteries are obstructed, resulting in reduced blood ﬂ  ow in the 
anterior spinal arteries and ischemic spinal cord. Abdominal 
pain and decreased urine output is a common malperfusion Vascular Health and Risk Management 2009:5 58
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Diagnostic strategy
and management
Timely and accurate diagnosis of acute aortic dissection in 
the ED remains a clinical challenge. Of the approximately 
4.4 million patients who present annually to the US ED’s for 
chest pain, only about 2,000 have AAD.9,10 Partly as a result, 
AAD is only correctly diagnosed in 15%–43% of patients in 
the initial presentation.11,12 A somewhat more humbling fact is 
that up to 53% of cases of AAD were diagnosed after patients 
have been in the hospital for more than 24 hours.13
History and physical examination alone are not 
sufﬁ  ciently sensitive to rule out an AAD. Although deﬁ  ni-
tive imaging tools are available to rule out an acute aortic 
syndrome, indiscriminate use of invasive diagnostic tools 
in patients with low pre-test probabilities will inevitably 
lead to false positives, and in turn, higher health care costs, 
unnecessary anxiety, and potential complications for patients. 
AAD, however, carries a mortality rate of 1%–2% per hour 
if unrecognized or not treated promptly. The human toll and 
medical legal implications for failures to diagnose an acute 
aortic dissection promptly are well publicized.14 The strategy 
of deferring the workup to the consultants or the admitting 
service is unacceptable.15 In approaching patients with acute 
chest pain in the ED, physicians need to methodically rule 
out the life threatening causes, ascertain the diagnosis, and 
initiate the stabilization measures. These life threatening 
causes include acute aortic syndrome, acute coronary 
syndrome, pulmonary embolus, tension pneumothorax, and 
esophageal rupture.
The evaluation should begin with an immediate 
assessment of vital signs and hemodynamic status. If patients 
are critically unstable, ACLS protocol should immediately 
be started. Patients should be placed on a monitor, have two 
large bore (18 gauge) intravenous access, and oxygen 
administered. An electrocardiogram (EKG) should be 
performed within 10 minutes of patient’s arrival. A portable 
chest X-ray should also be done concurrently with other 
stabilization measures. In patients at high risks for aortic 
dissection, 10 units of red blood cells should be typed and 
crossed.
In the setting of chest or back pain, the presence of a 
pulse differential between carotid, radial, or femoral arteries 
strongly suggests the diagnosis of acute aortic dissection 
(LR 5.7).9 The presence of focal neurological deﬁ  cits such as 
transient ischemic attack or hemiplegia even more strongly 
suggests the possibility of an aortic dissection. The likelihood 
ratio for aortic dissection among patients presenting with 
focal neurological deﬁ  cits range from 6.6 to 33.9 Chest X-rays 
ﬁ  ndings classically associated with aortic dissection include 
abnormal aortic contour, pleural effusion, displaced intimal 
calciﬁ  cation, and wide mediastinum. Although these classic 
radiographic ﬁ  ndings are not always present, collectively, 
up to 90% of patients with aortic dissection proved to have 
some abnormal ﬁ  ndings on chest X-rays. Absence of wide 
mediastinum and abnormal aortic contour on chest X-ray 
lowers the likelihood of aortic dissection (LR 0.3).9
Biochemical markers
The Holy Grail in the workup of acute aortic dissection is 
an inexpensive bedside blood test with sufﬁ  cient sensitivity 
(good negative predictive value) that physicians can use to 
rapidly rule out an acute dissection. Of the several biochemi-
cal markers that were evaluated in the last decade, the fol-
lowing three assays deserve further discussion.
Smooth muscle myosin heavy chain, a major component 
of the smooth muscle in the aortic medial layer, is released 
to the circulation shortly after the onset of dissection. In a 
pilot study, the assay (2.5 microgram/L) had a sensitivity of 
90.9% and speciﬁ  city of 98% in detecting acute aortic dissec-
tion as compared to healthy volunteers.16 These test numbers 
are, however, limited to patients with proximal dissection 
who present within 3 hours of onset of symptoms.
Type A Type B
Figure 3B Stanford classiﬁ  cation of aortic dissection. Stanford type A includes 
dissections that involve the ascending aorta, arch, and descending thoracic aorta. 
Stanford type B includes dissections that originate in the descending (and thoracoab-
dominal) aorta, regardless of any retrograde involvement of the arch. Vascular Health and Risk Management 2009:5 59
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Elastin is another major structural component of the medial 
layer of aortic wall. In a retrospective study using the assay 
for soluble elastin fragments (sELAF) that was developed 
by the authors,17 Shinohara and colleagues demonstrated 
that an ELISA measuring sELAF in the serum with the 
cutoff set at + 3 SD (standard deviation) above the mean 
of age-adjusted healthy subjects had a sensitivity of 88.9% 
(16/18) and speciﬁ  city of 99.8% (473/474).17 The positive 
(PPV) and negative predictive values (NPV) were 94.1% and 
98.8%, respectively. Based on the NPV, measuring sELAF 
would appear like an excellent test to rule out an acute aortic 
dissection. However, since this study was retrospective, data 
therein need to be conﬁ  rmed in a prospective conﬁ  rmatory 
multicenter study. More importantly, the ELISA for sELAF 
takes 3 hours to perform, a major drawback for a time 
sensitive condition such as acute aortic dissection. A positive 
test would require a follow-up radiologic conﬁ  rmatory test, 
which further prolongs the diagnosis.
Plasma D-dimer, a degradation product of cross-linked 
ﬁ  brin, has emerged as a promising diagnostic marker with 
high sensitivity for exclusion of acute aortic dissection. The 
rise in D-dimer is thought to result from the thrombogenic-
ity of the false lumen in AAD and the subsequent activa-
tion of the coagulation cascade. As such, D-dimer values 
are expected to be lower in proximal AAD (type A). In an 
earlier pooled analysis by Sodeck, a d-dimer 0.1 μg/ml 
is though to exclude all AAD (sensitivity of 100%).18 In 
a more recent pooled sensitivity analysis in EM literature, 
using a commonly used threshold for a positive D-dimer 
test of 0.5 μg/ml, Marill found that serum d-dimer had 
a sensitivity of 94%.19 The authors concluded that serum 
d-dimer can be used in patients with a low likelihood of AAD. 
Overall, a preponderance of recent studies support drawing 
D-dimer in the ED given its high sensitivity, noninvasiveness, 
broad availability and low cost.20–24
Imaging
The choice for the diagnostic imaging depends on patient’s 
stability, local expertise, and availability. The main goals 
in diagnostic imaging are to rapidly conﬁ  rm (or exclude) 
an AAD, classify the type/extent of the AAD, identify and 
locate the intimal tears, conﬁ  rm the presence of true/false 
lumen and whether a thrombus is present, assess any aortic 
side branch involvement, detect any aortic regurgitation, and 
discover any extravasation to the pericardium, mediastinum, 
or thoracic cavity.
A chest X-ray can detect abnormalities in 60%–90% 
of cases of AAD. Abnormalities that may suggest an AAD 
include an abnormal aortic knob, deviation of the trachea, 
main stem bronchus, or esophagus, wide mediastinum, 
pleural cap, or pleural effusion. A normal chest X-ray, 
however, can not be used to rule out an AAD. In unstable 
patients with strong suspicion of an AAD, chest X-rays may 
lead to further delay to deﬁ  nitive imaging and therapy and 
should be avoided.
Deﬁ  nitive imaging techniques are essential in the workup 
of AAD. Data from the 2002 IRAD show that computed 
tomography angiography (CTA) is used in 63% of cases of 
suspected AAD, followed transesophageal echocardiography 
(TEE) in 32%, aortography 4%, and magnetic resonance 
angiography (MRA) in 1%.25 Compared with the newer 
imaging techniques, aortography has a number of serious 
disadvantages, including the use of a heavy dose of IV 
contrast (1 mg/kg), the risks of an invasive procedure, and 
the extended time it takes to complete the procedure (up to 
2+ hours). As a result, this imaging method is rarely the ﬁ  rst 
diagnostic modality in the workup of AAD.
Computed tomography angiography, TEE and MRA 
have similar pooled sensitivity (98%–100%) and speciﬁ  city 
(95%–98%),26 although the pooled positive likelihood ratio 
appeared to be higher for MRA (positive likelihood ratio, 
25.3; 95% conﬁ  dence interval, 11.1–57.1) than for TEE 
(14.1; 6.0–33.2) or CTA (13.9; 4.2–46.0). CTA is widely 
available and relatively rapid, provides visualization of 
the entire aorta down to iliac arteries, and delineates the 
involvement of aortic side branches. It is usually the ﬁ  rst 
choice for imaging in the work up of AAD. Disadvantages 
with CTA include the requirement that patients be transported 
to the CTA suite, the use of potentially nephrotoxic contrast, 
and the inability to assess aortic insufﬁ  ciency.
Overall, CTA of the chest is the preferred ﬁ  rst diag-
nostic imaging method in hemodynamically stable 
patients (Figure 4). The choice for a second imaging study 
includes MRA or TEE, depending on clinical condition and 
local environment. MRA is highly accurate and does not 
require the use of a contrast dye. It is, however, usually not 
available on an emergency basis and requires patients to be 
in MRA suite for an extended period of time. Other issues 
such as claustrophobia, the use of ventilator, and patient’s 
use of metal devices (pacemakers, aneurysmal clips) may 
further complicate its routine use.25 TEE is a viable alterna-
tive in patients who are critically ill and/or hemodynamically 
unstable. The main advantages of a TEE include speed, good 
sensitivity and speciﬁ  city, and the fact that it can be per-
formed at the patient’s bedside in the ED. Its main limitations 
are lack of widespread expertise and 24/7 availability.Vascular Health and Risk Management 2009:5 60
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If the diagnosis can not be established using the 
aforementioned imaging modalities, the patient should be 
taken to the hybrid operating room. An intravascular ultra-
sound and/or aortography performed by the cardiothoracic 
surgeon will establish the deﬁ  nitive diagnosis (similar to 
diagnostic algorithm of traumatic aortic transection).27
Intravascular ultrasound (IVUS) is a novel approach 
in diagnosis of type B AAD that has the highest accuracy 
of any modality (Figure 5). IVUS has been demonstrated 
100% sensitivity and speciﬁ  city during endovascular diag-
nosis and treatment of complicated type B aortic dissec-
tion.28 Furthermore, IVUS is a critical imaging modality for 
endovascular treatment options for type B AAD.29
Management
The modern surgical treatment for AAD, including those for 
acute type B aortic dissection, began after the landmark aortic 
operation by Drs Cooley and DeBakey in the 1950’s.30 In the 
decades following this sentinel event, patients with type B 
aortic dissection were mostly treated surgically. The medical 
management of acute type B AAD began to gain credence 
with the concept of antiimpulsive therapy as described by 
Wheat.31 He was one of the ﬁ  rst to demonstrate the impor-
tance of the force of contraction (dP/dtmax) and blood pres-
sure in the propagation of AAD in a dog model.32 Starting 
in the early 70’s, medical management of uncomplicated 
type B AAD increasingly became the standard of care 
due to availability of potent beta-blockers and the lower 
mortality compared to surgical approach (for type A, early 
mortality rates of 10% vs. 35%, respectively).33 Today, the 
antiimpulsive and antihypertensive combination therapy 
remains the cornerstone of modern medical management 
of type B AAD. Table 2 illustrates the authors’ approach to 
the diagnosis and management of an acute aortic dissection 
(AAD) in the ED.
At triage, patients who present to the ED with sudden 
onset of chest, back, or abdominal pain should be quickly 
brought to a room to be examined by a physician. Prompt 
diagnosis and treatment of patients with suspected AAD is 
essential for improved outcome. The abbreviated history 
and physical examination should focus on time of onset, 
risk factors for aortic dissection, and ﬁ  ndings that are 
consistent with AAD (Table 2). Patients should have IV’s 
and A-line established, supplemental oxygen, be put on 
a cardiac monitor, an EKG, portable chest X-ray, blood 
draws, and be typed and crossed for 10 units of PRBC’s. 
Surgical consultation should be initiated as soon as the 
emergency physician is comfortable with his/her clinical 
impression.
Pain should be treated with appropriate analgesics 
(eg, morphine). Heart rate and hypertension should be 
aggressively controlled with β-blockers.34 An arterial 
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Figure 5 Intravascular imaging of aortic dissection. Figure 4 Computer tomography with enhanced contrast showing type B 
dissection.Vascular Health and Risk Management 2009:5 61
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Table 2 Approach to acute aortic dissections (AAD) in the emergency department
1) Have a high index of suspicion for AAD
 a)  History: 
    i)  Sudden onset, severe, sharp or tearing back pain, chest pain, shoulder pain, or abdominal pain
  ii)    Older than 60 years, history of hypertension, aortic dissection or aortic aneurysm (of family history of such), previous cardiac surgery, con-
nective tissue disorder (Bicuspid aortic valve, Marfan syndrome, Ehler-Danlos syndrome, Loeys-Dietz syndrome), or peripartum
  b) Physical examination: 
  (1)  Pulse  deﬁ  cit, blood pressure differential in various extremities
  (2)  Neurological  deﬁ  cits
  (3)  Abdominal  pain,  ﬂ  ank pain
2) General measures:  
  a) Establish two large bore (18gauge) IV’s 
  b) Administer supplemental oxygen by nasal cannula or nonrebreather mask 
  c) Put patient on cardiac monitor 
  d) Get an EKG, portable chest X-ray, place a Foley catheter 
  e) Obtain CBC, chemistry panel, coagulation panel, UA, CK,   Troponin, d-dimer 
  f) Type and cross 10 units packed red blood cells (PRBC’s) 
  g) Set up an arterial line 
3) Early cardiothoracic surgical consultation  
4) Deﬁ  nitive imaging:   
  a) Computed tomography angiogram (CTA) 
 b)  Transesophageal  echocardiogram 
  c) Magnetic resonance angiogram (MRA) 
  d) Intravascular ultrasound 
 e)  Aortography 
5) Blood pressure, heart rate, and pain management   
  a) First line: β-blockers 
    i)  Labetalol, bolus (15 mg) ± a drip (5 mg/hour),
  b) If hypertension persists, add: 
    i)  Nicardipine drip (starting dose: 5 mg/h)
  c) If tachycardia persists, add: 
    i)  Esmolol (loading 0.5 mg/kg over 2–5 min, followed by a drip of 10–20 μg/kg/min)
    ii)  Diltiazem drip (loading 0.25 mg/kg over 2–5 min, followed by a drip of 5mg/h)
 d)  Goals: 
  (1)  Heart  rate  60 beats/min
    (2) Systolic blood pressure 100 mm Hg
  e) Morphine (for pain relief) 
6) Hemodynamically unstable patients   
  a) Tracheal intubation, mechanical ventilation 
  b) Blood pressure support with crystalloid and colloid (PRBC’s if rupture is suspected) 
  c) TEE at bedside in the Emergency Department or in the OR 
  d) Pericardiocentesis is not recommended (class III)
vasodilator without the reﬂ  ex tachycardia (eg, nicardipine), 
can be added as second line drugs for refractory hypertension. 
β-blockers are the ﬁ  rst line drugs because they control the 
maximal force of left ventricular contraction (dP/dtmax) in 
addition to controlling HR and BP. This helps reduce further 
dissection, branch-vessel malperfusion and weakening of the 
aortic wall. Common β-blockers include labetalol, esmolol, 
metoprolol, and atenolol. Targeted HR and systolic BP 
should be 60 beats/min and 100 mm Hg, respectively. In 
patients with potential intolerance to β-blockers (eg, asthma, 
heart failure), a test dose of a short acting β-blocker such 
as esmolol should be tried.35 If β-blockers can not be used, 
calcium channel blockers (eg, nicardipine, clevidipine or 
diltiazem) might be alternatives to control blood pressure in 
these patients. Hydralazine and sodium nitroprusside have 
been used in the past for medical management of type B 
AAD. Although these agents reduce blood pressure, they 
increase the maximal force of left ventricular contraction 
(dP/dtmax) and cause reﬂ  ex tachycardia and are, thus, con-
traindicated in patients with AAD.
Hemodynamically unstable patients with type B AAD are 
either in hemorrhagic shock or septic/metabolic shock from 
visceral or limb malperfusion. They should be endotracheally 
intubated and ﬂ  uid resuscitated with crystalloid, PRBC’s, 
or other colloid. In these patients, a TEE or CTA are the 
preferred diagnostic tools, depending on the hospital setting. Vascular Health and Risk Management 2009:5 62
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If the diagnosis of a complicated type B AAD is conﬁ  rmed, 
patients should be immediately brought to a hybrid 
operating room for endovascular and/or surgical treatment 
options. Endovascular or surgical options may be offered to 
hemodynamically stable patients with a complicated type 
B AAD. Table 3 lists the indications for endovascular or 
surgical intervention in patients with type B AAD.
Outcome
The short term prognosis for patients with type B AAD is 
better than those with type A and the medical management of 
type B AAD is associated with less mortality compared to the 
open surgical intervention approach. Overall, 89% of patients 
with type B AAD survive to hospital discharge, although the 
in-hospital survival rates were as low as 29% for the highest 
risk group, 64% for the intermediate, and 97% for the lowest 
risk group.6,36  Aortic rupture, shock, and malperfusion are the 
most important in-hospital risks leading to poor outcome in 
up to 20% of these patients.6,35 Of survivors, 80% will develop 
aneurysmal dilatation of the false lumen, requiring cardio-
thoracic surgical intervention in one third of the cases.35,37,38 
Therefore, although medical management of patients with 
type B AAD is the standard of care at the moment, it is far 
from being an option with acceptable results to patients with 
uncomplicated type B AAD.
The long term prognosis for patients with type B AAD 
is poor. Data from IRAD indicated about 1 out of 4 patients 
with type B dissection died at the 3-year mark regardless of 
the mode of therapy. The 3-year rates of survival were 77.6%, 
82.8%, and 76.2% for patients treated medically, surgically, 
and with endovascular therapy, respectively.36 Umana and 
colleauges reported the outcome of 189 patients with type 
B aortic dissection over a 36-year period. Actuarial survival 
for all patients was 71%, 60%, 35% and 17% at one, ﬁ  ve, 
10, and 15 years regardless of medical or surgical therapy.33 
A diameter 4 cm, patent false lumen, and a partially throm-
bosed false lumen are independent predictors of poor long 
term outcome for type B dissection.39,40
Future development
Given the disappointing results of medical and surgical 
therapy in uncomplicated type B AAD, there has been inter-
est in use of endovascular stenting along with antiimpulsive 
and antihypertensive treatment. The endovascular therapy 
is based on the concept that obliteration and thrombosis of 
the false lumen may result in improved long-term outcome. 
The INSTEAD trial was designed to address this question, 
but was associated with methodological ﬂ  aws by including 
patients with chronic type B aortic dissection.41 Ongoing and 
future trials will shed light on this issue. For complicated 
type B AAD, endovascular therapies are becoming the 
standard of care in the Centers of Excellence, because they 
have shown to have a better outcome compared to the open 
repair approach.29,42,43
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